Coherus Announces Positive Final Overall Survival Results of JUPITER-02 Phase 3 Trial Evaluating Toripalimab in Nasopharyngeal Carcinoma
JUPITER-02 Final Overall Survival Analysis in Intent-To-Treat Population Presented at ASCO 2023 – Toripalimab plus…